BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright ©The Author(s) 2025.
World J Gastrointest Pharmacol Ther. Sep 5, 2025; 16(3): 107167
Published online Sep 5, 2025. doi: 10.4292/wjgpt.v16.i3.107167
Table 1 Comparative analysis of baseline features
Characteristic
ERCP (n = 12)
PTBD (n = 21)
P value
Severe cholangitis (n = 33)12 (36.4)21 (63.6)
Mean age (years)60.462.70.63
Female4 (33.3)8 (38.1)0.78
Male8 (66.7)13 (61.9)
Charlson Comorbidity Index score3.3 ± 2.45.0 ± 2.70.09
Comorbidities
Hypertension7 (58.3)12 (57.1)0.94
Diabetes4 (33.3)8 (38.1)0.78
Ischemic heart disease1 (8.3)6 (28.6)0.17
Chronic kidney disease0 (0.0)2 (9.5)0.27
Chronic liver disease1 (8.3)1 (4.8)0.67
Nonalcoholic fatty liver disease1 (8.3)0 (0.0)0.17
Clinical features
Abdominal pain8 (66.7)18 (85.7)0.19
Fever7 (58.3)13 (61.9)0.80
Jaundice5 (41.7)15 (71.4)0.09
Nausea and vomiting5 (41.7)5 (23.8)0.28
Weight loss1 (8.3)7 (33.3)0.10
Altered consciousness1 (8.3)5 (23.8)0.26
Lethargy0 (0.0)3 (14.3)0.17
Vitals
Temperature37.0 ± 0.437.3 ± 0.40.11
Heart rate96.2 ± 14.8102.3 ± 19.50.35
Mean arterial pressure64.9 ± 7.460.7 ± 4.60.05
Respiratory rate20.7 ± 6.120.6 ± 2.10.97
SpO295.1 ± 2.694.9 ± 1.30.79
Laboratory investigations
Hemoglobin11.2 ± 2.810.3 ± 1.80.29
Total leukocyte count18.2 ± 7.818.2 ± 8.70.98
Platelets216.7 ± 126.3223 ± 130.40.88
Prothrombin time15.6 ± 7.316.2 ± 8.40.83
Organ severity
Cardiac dysfunction6 (50.0)17 (80.9)0.06
Hepatic dysfunction4 (33.3)10 (47.6)0.42
Renal dysfunction3 (25.0)8 (38.1)0.44
Hematological dysfunction3 (25.0)4 (19.1)0.68
Neurological dysfunction0 (0.0)3 (14.3)0.17
Pulmonary dysfunction0 (0.0)2 (9.6)0.27
Table 2 Technical success, complications and outcome of patients
Outcome
ERCP (n = 12)
PTBD (n = 21)
P value
Technical success12 (100.0)21 (100.0)
Therapeutic success11 (91.7)12 (57.1)0.03
Complications
Total complications2 (16.7)12 (57.1)0.02
Hospital acquired infections2 (16.7)11 (52.4)0.04
Pulmonary complications1 (8.3)6 (28.6)0.17
Dislodgement0 (0.0)3 (14.3)0.17
Arrhythmias0 (0.0)1 (4.7)0.44
Bleeding0 (0.0)2 (4.8)0.44
Mortality0 (0.0)5 (23.8)0.06
Readmission1 (8.3)4 (19.1)0.40